FDA announces steps to increase efficiency in preliminary stages of innovative drug development

被引：0

|

作者：

不详

机构：

来源：

JOURNAL OF INVESTIGATIVE MEDICINE | 2006年 / 54卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：110 / 110

页数：1

相关论文

共 12 条

[1] FDA announces two initiatives to accelerate drug development
不详
[J]. NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (02) : 95 - 95
[2] FDA outlines steps for individualized drug development
Asher Mullard
[J]. Nature Reviews Drug Discovery, 2021, 20 : 91 - 91
[3] FDA outlines steps for individualized drug development
Mullard, Asher
[J]. NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (02) : 91 - 91
[4] Sugarcane Technology Center - Development of Innovative Technologies to Increase Agricultural Efficiency of the Sugarcane Industry
Melotto-Passarin, D. M.
Faroni, C. E.
Monteiro, M.
Marchesini, A. B.
Ferreira, W. J.
Fernandes, R. Z.
Andia, M. I. B.
Campos, D. O.
Pontes, J. H. M.
Marchi, A. S.
Ferres, D. H. S.
[J]. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2015, 51 : S16 - S16
[5] Development of innovative activity of the enterprises of construction branch in the direction of increase in resource-saving and energy efficiency
Papelniuk, Oksana
[J]. ENERGY MANAGEMENT OF MUNICIPAL TRANSPORTATION FACILITIES AND TRANSPORT (EMMFT 2017), 2017, 90
[6] Expert rater assisted score evaluation: a new method to increase efficiency in drug development programs
Schoemaker, J.
Gaur, R.
Chawla, V.
Szegedi, A.
[J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S482 - S483
[7] Model-based approaches to increase efficiency of drug development in schizophrenia: a can't miss opportunity
Nucci, Gianluca
Gomeni, Roberto
Poggesi, Italo
[J]. EXPERT OPINION ON DRUG DISCOVERY, 2009, 4 (08) : 837 - 856
[8] Regulatory science under the Generic Drug User Fee Act of 2012 (GDUFA), including FDA's consideration of complex drug substances and innovative analytical method development
Jiang, Xiaohui
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
[9] Nontraditional approaches to first-in-human studies to increase efficiency of drug development, will microdose studies make a significant impact?
Boyd, R. A.
Lalonde, R. L.
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (01) : 24 - 26
[10] Model-based approaches to increase efficiency of drug development in schizophrenia: a can't miss opportunity (vol 4, pg 837, 2009)
Nucci, G.
Gomeni, R.
Poggesi, I
[J]. EXPERT OPINION ON DRUG DISCOVERY, 2010, 5 (09) : 907 - 907